Reduction in insulin clearance has emerged as a major risk factor in metabolic syndrome, including NAFLD, in Hispanics (particularly of Mexican descent [19]), African-Americans [20], African-Caribbeans [21], and Native Americans [22]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.